DISHMAN CARBOGEN AMCIS
Back to Balance Sheet
|
DISHMAN CARBOGEN AMCIS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹9,986 Cr | ₹9,571 Cr | ₹9,439 Cr | ₹8,634 Cr | ₹8,356 Cr |
What is the latest Total Liabilities ratio of DISHMAN CARBOGEN AMCIS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹9,986 Cr |
| Mar2024 | ₹9,571 Cr |
| Mar2023 | ₹9,439 Cr |
| Mar2022 | ₹8,634 Cr |
| Mar2021 | ₹8,356 Cr |
How is Total Liabilities of DISHMAN CARBOGEN AMCIS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹9,986 Cr | 4.34 | |
| Mar2024 | ₹9,571 Cr | 1.39 | |
| Mar2023 | ₹9,439 Cr | 9.33 | |
| Mar2022 | ₹8,634 Cr | 3.33 | |
| Mar2021 | ₹8,356 Cr | - | |
Compare Total Liabilities of peers of DISHMAN CARBOGEN AMCIS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DISHMAN CARBOGEN AMCIS | ₹2,623.3 Cr | -2.4% | -15.7% | -40.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DISHMAN CARBOGEN AMCIS | -2.4% |
-15.7% |
-40.2% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses